Dicerna Pharmaceutic
(DRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 197,801 | 245,479 | 152,816 | 47,226 | 100,321 |
| Marketable Securities | 471,408 | 461,411 | 196,065 | 265,484 | 244,969 |
| Receivables | 12 | 15,000 | 200,354 | 3,000 | N/A |
| TOTAL | $681,762 | $730,496 | $556,169 | $320,398 | $350,248 |
| Non-Current Assets | |||||
| PPE Net | 9,135 | 7,500 | 7,076 | 5,508 | 4,915 |
| Other Non-Current Assets | 41,513 | 40,793 | 34,164 | 10,344 | 6,233 |
| TOTAL | $50,648 | $48,293 | $41,240 | $15,852 | $11,148 |
| Total Assets | $732,410 | $778,789 | $597,409 | $336,250 | $361,396 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,764 | 6,497 | 6,077 | 3,407 | 5,636 |
| Accrued Expenses | 27,009 | 19,087 | 20,042 | 18,585 | 10,515 |
| TOTAL | $258,926 | $252,304 | $241,735 | $119,361 | $95,872 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 221,343 | 223,556 | 212,258 | 95,659 | 78,073 |
| Other Non-Current Liabilities | 20,427 | 21,073 | 20,749 | 545 | 1,035 |
| TOTAL | $311,316 | $348,579 | $203,479 | $82,522 | $105,359 |
| Total Liabilities | $570,242 | $600,883 | $445,214 | $201,883 | $201,231 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,459 | 73,916 | 73,751 | 68,431 | 68,360 |
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | -579,628 | -547,808 | -525,316 | -485,646 | -454,856 |
| Other shareholders' equity | 0 | 0 | 0 | -3 | 0 |
| TOTAL | $162,168 | $177,906 | $152,195 | $134,367 | $160,165 |
| Total Liabilities And Equity | $732,410 | $778,789 | $597,409 | $336,250 | $361,396 |